CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
SHARE-S Implementation Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04337203
NCT04337203N/ACompleted
CompareCT.gov

SHARE-S Aim 3: Shared Healthcare Actions & Reflections Electronic Systems in Survivorship

Wake Forest University Health Sciences·interventional·Posted Apr 7, 2020·Updated Jun 28, 2023

In Brief

A clinical study evaluating SHARE-S Implementation Program for Cancer and 3 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The primary purpose of this study is conduct a pilot study testing the study protocols, implementation program, and mixed-methods data collection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer, Survivorship, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 7, 2020
Enrollment StartSep 8, 2020
Primary CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.2 years ago

Interventions

SHARE-S Implementation Programbehavioral

The program consists of three components: An electronic referral among clinical teams for potential participants, patient engagement with survivorship care planning guidelines through self-management/health coaching. One coaching call before a clinic visit (60 minutes) and two coaching calls after the clinic visit (30 minutes each). Participants will also receive automated, tailored text messages (daily for three weeks before and after a clinic visit for a total of six weeks).